1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Tomizawa, T.
Koshiba, S.
Watanabe, S.
Harada, T.
Kigawa, T.
Yokoyama, S.
RIKEN Structural Genomics/Proteomics Initiative (RSGI)
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be Published
0353
Solution structure of the 13th filamin domain from human Filamin-B
10.2210/pdb2dj4/pdb
pdb_00002dj4
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
11197.574
Filamin-B
Filamin domain
1
man
polymer
FLN-B, Beta-filamin, Actin-binding-like protein, Thyroid autoantigen, Truncated actin-binding protein, Truncated ABP, ABP-280 homolog, ABP-278, Filamin 3, Filamin homolog 1, Fh1
no
no
GSSGSSGVVDPSKVKIAGPGLGSGVRARVLQSFTVDSSKAGLAPLEVRVLGPRGLVEPVNVVDNGDGTHTVTYTPSQEGP
YMVSVKYADEEIPRSPFKVKVLPTYDAS
GSSGSSGVVDPSKVKIAGPGLGSGVRARVLQSFTVDSSKAGLAPLEVRVLGPRGLVEPVNVVDNGDGTHTVTYTPSQEGP
YMVSVKYADEEIPRSPFKVKVLPTYDAS
A
hsk003002600.6
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
Cell-free protein synthesis
FLNB
9606
Homo sapiens
Cell free synthesis
PLASMID
P060123-13
RIKEN Structural Genomics/Proteomics Initiative
RSGI
NPPSFA, National Project on Protein Structural and Functional Analyses
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2006-10-01
1
1
2008-04-30
1
2
2011-07-13
1
3
2022-03-09
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_ref_seq_dif.details
Y
PDBJ
Y
PDBJ
2006-03-31
REL
REL
target function, structures with the lowest energy, structures with the least restraint violations
100
20
3D_15N-separated_NOESY
3D_13C-separated_NOESY
120mM
7.0
ambient
296
K
torsion angle dynamics, restrainted molecular dynamics
1
lowest energy
1.16mM Filamin domain U-15N,13C; 20mM d-Tris-HCl(pH 7.0); 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 90% H2O, 10% D2O
90% H2O/10% D2O
Bruker
collection
TopSpin
1.3
Delaglio, F.
processing
NMRPipe
20060324
Johnson, B.A.
data analysis
NMRView
5.0.4
Kobayashi, N.
data analysis
KUJIRA
0.9742
Guntert, P.
structure solution
CYANA
2.0.17
Guntert, P.
refinement
CYANA
2.0.17
900
Bruker
AVANCE II
GLY
1
n
1
GLY
1
A
SER
2
n
2
SER
2
A
SER
3
n
3
SER
3
A
GLY
4
n
4
GLY
4
A
SER
5
n
5
SER
5
A
SER
6
n
6
SER
6
A
GLY
7
n
7
GLY
7
A
VAL
8
n
8
VAL
8
A
VAL
9
n
9
VAL
9
A
ASP
10
n
10
ASP
10
A
PRO
11
n
11
PRO
11
A
SER
12
n
12
SER
12
A
LYS
13
n
13
LYS
13
A
VAL
14
n
14
VAL
14
A
LYS
15
n
15
LYS
15
A
ILE
16
n
16
ILE
16
A
ALA
17
n
17
ALA
17
A
GLY
18
n
18
GLY
18
A
PRO
19
n
19
PRO
19
A
GLY
20
n
20
GLY
20
A
LEU
21
n
21
LEU
21
A
GLY
22
n
22
GLY
22
A
SER
23
n
23
SER
23
A
GLY
24
n
24
GLY
24
A
VAL
25
n
25
VAL
25
A
ARG
26
n
26
ARG
26
A
ALA
27
n
27
ALA
27
A
ARG
28
n
28
ARG
28
A
VAL
29
n
29
VAL
29
A
LEU
30
n
30
LEU
30
A
GLN
31
n
31
GLN
31
A
SER
32
n
32
SER
32
A
PHE
33
n
33
PHE
33
A
THR
34
n
34
THR
34
A
VAL
35
n
35
VAL
35
A
ASP
36
n
36
ASP
36
A
SER
37
n
37
SER
37
A
SER
38
n
38
SER
38
A
LYS
39
n
39
LYS
39
A
ALA
40
n
40
ALA
40
A
GLY
41
n
41
GLY
41
A
LEU
42
n
42
LEU
42
A
ALA
43
n
43
ALA
43
A
PRO
44
n
44
PRO
44
A
LEU
45
n
45
LEU
45
A
GLU
46
n
46
GLU
46
A
VAL
47
n
47
VAL
47
A
ARG
48
n
48
ARG
48
A
VAL
49
n
49
VAL
49
A
LEU
50
n
50
LEU
50
A
GLY
51
n
51
GLY
51
A
PRO
52
n
52
PRO
52
A
ARG
53
n
53
ARG
53
A
GLY
54
n
54
GLY
54
A
LEU
55
n
55
LEU
55
A
VAL
56
n
56
VAL
56
A
GLU
57
n
57
GLU
57
A
PRO
58
n
58
PRO
58
A
VAL
59
n
59
VAL
59
A
ASN
60
n
60
ASN
60
A
VAL
61
n
61
VAL
61
A
VAL
62
n
62
VAL
62
A
ASP
63
n
63
ASP
63
A
ASN
64
n
64
ASN
64
A
GLY
65
n
65
GLY
65
A
ASP
66
n
66
ASP
66
A
GLY
67
n
67
GLY
67
A
THR
68
n
68
THR
68
A
HIS
69
n
69
HIS
69
A
THR
70
n
70
THR
70
A
VAL
71
n
71
VAL
71
A
THR
72
n
72
THR
72
A
TYR
73
n
73
TYR
73
A
THR
74
n
74
THR
74
A
PRO
75
n
75
PRO
75
A
SER
76
n
76
SER
76
A
GLN
77
n
77
GLN
77
A
GLU
78
n
78
GLU
78
A
GLY
79
n
79
GLY
79
A
PRO
80
n
80
PRO
80
A
TYR
81
n
81
TYR
81
A
MET
82
n
82
MET
82
A
VAL
83
n
83
VAL
83
A
SER
84
n
84
SER
84
A
VAL
85
n
85
VAL
85
A
LYS
86
n
86
LYS
86
A
TYR
87
n
87
TYR
87
A
ALA
88
n
88
ALA
88
A
ASP
89
n
89
ASP
89
A
GLU
90
n
90
GLU
90
A
GLU
91
n
91
GLU
91
A
ILE
92
n
92
ILE
92
A
PRO
93
n
93
PRO
93
A
ARG
94
n
94
ARG
94
A
SER
95
n
95
SER
95
A
PRO
96
n
96
PRO
96
A
PHE
97
n
97
PHE
97
A
LYS
98
n
98
LYS
98
A
VAL
99
n
99
VAL
99
A
LYS
100
n
100
LYS
100
A
VAL
101
n
101
VAL
101
A
LEU
102
n
102
LEU
102
A
PRO
103
n
103
PRO
103
A
THR
104
n
104
THR
104
A
TYR
105
n
105
TYR
105
A
ASP
106
n
106
ASP
106
A
ALA
107
n
107
ALA
107
A
SER
108
n
108
SER
108
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
LYS
15
A
N
LYS
15
A
O
ASP
36
A
O
ASP
36
A
N
GLN
31
A
N
GLN
31
A
O
TYR
73
A
O
TYR
73
A
O
THR
70
A
O
THR
70
A
N
VAL
62
A
N
VAL
62
A
O
GLU
57
A
O
GLU
57
A
N
VAL
49
A
N
VAL
49
A
N
LEU
50
A
N
LEU
50
A
O
MET
82
A
O
MET
82
A
N
GLY
79
A
N
GLY
79
A
O
VAL
101
A
O
VAL
101
1
A
PRO
75
-69.73
97.12
1
A
PRO
80
-69.78
88.07
1
A
GLU
91
-54.54
109.50
1
A
ILE
92
-47.52
152.95
1
A
PRO
93
-69.74
3.93
1
A
PRO
96
-69.70
-179.97
1
A
THR
104
-34.70
-34.51
2
A
SER
3
36.77
42.26
2
A
PRO
75
-69.74
90.45
2
A
PRO
80
-69.83
86.59
2
A
ILE
92
-49.24
153.20
2
A
PRO
93
-69.65
4.41
2
A
THR
104
-36.34
-30.42
2
A
ALA
107
-111.66
78.73
3
A
SER
6
-69.48
90.54
3
A
PRO
75
-69.73
91.90
3
A
PRO
80
-69.72
90.85
3
A
PRO
93
-69.76
4.29
3
A
PRO
96
-69.69
-179.41
3
A
THR
104
-33.97
-36.21
4
A
PRO
75
-69.77
98.12
4
A
PRO
80
-69.78
92.76
4
A
ASP
89
74.22
31.74
4
A
PRO
93
-69.80
4.47
4
A
THR
104
-35.21
-31.75
5
A
PRO
11
-69.76
1.49
5
A
PRO
75
-69.76
92.92
5
A
PRO
80
-69.76
89.13
5
A
TYR
87
-160.44
110.54
5
A
GLU
91
-54.39
108.38
5
A
ILE
92
-46.90
153.02
5
A
PRO
93
-69.74
4.68
5
A
PRO
96
-69.72
-178.53
5
A
THR
104
-34.83
-35.32
6
A
PRO
75
-69.80
95.04
6
A
PRO
80
-69.76
89.15
6
A
PRO
93
-69.74
4.74
6
A
PRO
96
-69.69
-179.92
6
A
THR
104
-34.83
-32.19
6
A
TYR
105
-90.05
38.71
6
A
ALA
107
-108.41
78.53
7
A
PRO
11
-69.74
0.78
7
A
PRO
80
-69.78
93.93
7
A
ASP
89
73.47
31.40
7
A
GLU
91
-53.36
107.90
7
A
ILE
92
-45.93
153.00
7
A
PRO
93
-69.75
4.31
7
A
THR
104
-35.58
-32.15
7
A
ALA
107
-79.87
43.45
8
A
PRO
75
-69.73
91.39
8
A
PRO
80
-69.72
86.19
8
A
TYR
87
-160.18
109.47
8
A
ILE
92
-49.41
153.03
8
A
PRO
93
-69.74
3.85
8
A
THR
104
-36.11
-30.82
8
A
ALA
107
-81.91
44.03
9
A
VAL
8
-33.97
135.73
9
A
PRO
11
-69.81
0.37
9
A
PRO
75
-69.75
94.59
9
A
PRO
80
-69.78
90.13
9
A
ASP
89
71.04
33.50
9
A
PRO
93
-69.68
4.33
9
A
THR
104
-34.12
-33.40
9
A
ALA
107
-68.02
81.87
10
A
PRO
11
-69.76
0.30
10
A
PRO
75
-69.81
94.39
10
A
PRO
80
-69.65
93.90
10
A
PRO
93
-69.66
5.83
10
A
THR
104
-39.38
-27.48
10
A
TYR
105
-82.25
38.54
10
A
ASP
106
36.44
29.37
11
A
PRO
75
-69.75
94.52
11
A
SER
76
-39.38
-27.20
11
A
PRO
80
-69.71
81.66
11
A
PRO
93
-69.74
6.20
11
A
THR
104
-33.87
-35.05
12
A
SER
6
-83.00
40.00
12
A
VAL
8
-42.99
155.74
12
A
PRO
75
-69.74
92.97
12
A
PRO
80
-69.68
84.20
12
A
PRO
93
-69.68
4.34
12
A
THR
104
-34.73
-32.67
13
A
PRO
75
-69.73
94.38
13
A
PRO
80
-69.74
83.24
13
A
PRO
93
-69.80
6.02
13
A
THR
104
-33.96
-34.94
13
A
ALA
107
-68.06
82.92
14
A
SER
6
34.65
42.14
14
A
PRO
75
-69.74
99.01
14
A
PRO
80
-69.80
92.49
14
A
ILE
92
-49.50
152.86
14
A
PRO
93
-69.83
4.11
14
A
THR
104
-39.02
-25.66
14
A
ASP
106
-164.53
113.27
14
A
ALA
107
-104.68
43.68
15
A
SER
3
-104.27
42.59
15
A
PRO
75
-69.73
89.09
15
A
PRO
80
-69.71
86.45
15
A
PRO
93
-69.80
5.15
15
A
THR
104
-34.61
-32.87
16
A
VAL
8
-38.10
152.34
16
A
PRO
11
-69.74
3.11
16
A
PRO
75
-69.76
93.42
16
A
PRO
80
-69.72
93.71
16
A
ASP
89
71.40
30.73
16
A
PRO
93
-69.86
4.27
16
A
THR
104
-39.60
-30.33
17
A
SER
6
-88.70
42.15
17
A
PRO
75
-69.82
93.99
17
A
PRO
80
-69.98
91.24
17
A
PRO
93
-69.82
4.89
17
A
THR
104
-34.01
-33.25
17
A
TYR
105
-81.82
48.09
17
A
ASP
106
-90.19
35.93
17
A
ALA
107
-81.23
41.63
18
A
SER
6
-93.26
43.15
18
A
PRO
75
-69.81
90.22
18
A
PRO
80
-69.73
89.87
18
A
PRO
93
-69.75
5.72
18
A
THR
104
-35.24
-31.89
18
A
ALA
107
-84.81
41.26
19
A
SER
3
-45.42
163.93
19
A
PRO
75
-69.79
93.30
19
A
PRO
80
-69.84
83.45
19
A
PRO
93
-69.77
4.69
19
A
PRO
96
-69.80
-178.83
19
A
THR
104
-34.12
-35.21
19
A
ALA
107
-90.76
36.31
20
A
PRO
11
-69.74
2.40
20
A
PRO
75
-69.69
94.62
20
A
PRO
80
-69.75
84.06
20
A
PRO
93
-69.73
8.30
20
A
THR
104
-33.87
-36.16
20
A
ALA
107
-88.18
41.61
Solution structure of the 13th filamin domain from human Filamin-B
1
N
N
STRUCTURAL PROTEIN
beta-sandwich, immunoglobulin-like fold, filamin domain, NPPSFA, National Project on Protein Structural and Functional Analyses, Structural Genomics, RIKEN Structural Genomics/Proteomics Initiative, RSGI, STRUCTURAL PROTEIN
A
SER
95
A
SER
95
1
A
PRO
96
A
PRO
96
-0.10
A
SER
95
A
SER
95
2
A
PRO
96
A
PRO
96
-0.01
A
SER
95
A
SER
95
3
A
PRO
96
A
PRO
96
-0.13
A
SER
95
A
SER
95
4
A
PRO
96
A
PRO
96
0.08
A
SER
95
A
SER
95
5
A
PRO
96
A
PRO
96
-0.08
A
SER
95
A
SER
95
6
A
PRO
96
A
PRO
96
-0.11
A
SER
95
A
SER
95
7
A
PRO
96
A
PRO
96
-0.12
A
SER
95
A
SER
95
8
A
PRO
96
A
PRO
96
0.02
A
SER
95
A
SER
95
9
A
PRO
96
A
PRO
96
-0.05
A
SER
95
A
SER
95
10
A
PRO
96
A
PRO
96
-0.02
A
SER
95
A
SER
95
11
A
PRO
96
A
PRO
96
-0.03
A
SER
95
A
SER
95
12
A
PRO
96
A
PRO
96
-0.05
A
SER
95
A
SER
95
13
A
PRO
96
A
PRO
96
0.11
A
SER
95
A
SER
95
14
A
PRO
96
A
PRO
96
-0.05
A
SER
95
A
SER
95
15
A
PRO
96
A
PRO
96
0.02
A
SER
95
A
SER
95
16
A
PRO
96
A
PRO
96
0.02
A
SER
95
A
SER
95
17
A
PRO
96
A
PRO
96
-0.02
A
SER
95
A
SER
95
18
A
PRO
96
A
PRO
96
-0.05
A
SER
95
A
SER
95
19
A
PRO
96
A
PRO
96
0.09
A
SER
95
A
SER
95
20
A
PRO
96
A
PRO
96
0.02
FLNB_HUMAN
UNP
1
1418
O75369
1418
1518
2DJ4
8
108
O75369
A
1
8
108
1
cloning artifact
GLY
1
2DJ4
A
O75369
UNP
1
1
cloning artifact
SER
2
2DJ4
A
O75369
UNP
2
1
cloning artifact
SER
3
2DJ4
A
O75369
UNP
3
1
cloning artifact
GLY
4
2DJ4
A
O75369
UNP
4
1
cloning artifact
SER
5
2DJ4
A
O75369
UNP
5
1
cloning artifact
SER
6
2DJ4
A
O75369
UNP
6
1
cloning artifact
GLY
7
2DJ4
A
O75369
UNP
7
1
MET
SEE REMARK 999
VAL
61
2DJ4
A
O75369
UNP
1471
61
4
4
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
LYS
15
A
LYS
15
A
ALA
17
A
ALA
17
A
GLN
31
A
GLN
31
A
ASP
36
A
ASP
36
A
THR
68
A
THR
68
A
TYR
73
A
TYR
73
A
VAL
62
A
VAL
62
A
ASP
63
A
ASP
63
A
VAL
56
A
VAL
56
A
GLU
57
A
GLU
57
A
LEU
45
A
LEU
45
A
LEU
50
A
LEU
50
A
GLY
79
A
GLY
79
A
TYR
87
A
TYR
87
A
PHE
97
A
PHE
97
A
VAL
101
A
VAL
101